Overactive bladder symptoms and voiding dysfunction in neurologically normal women

Neurourology and Urodynamics

Volumn 31, Issue 4, 2012, Pages 422-428

  Espuña Pons, Montserrat ^a   Cardozo, Linda ^b   Chapple, Christopher ^c   Sievert, Karl Dietrich ^d   Van Kerrebroeck, Phillip ^e   Kirby, Michael G ^f  

^a UNIVERSITY OF BARCELONA   (Spain)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

bladder obstruction; neurologically normal; non neurogenic; overactive bladder; voiding dysfunction

Indexed keywords

ALFUZOSIN; TAMSULOSIN; TOLTERODINE;

AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX; BEHAVIOR THERAPY; BLADDER FUNCTION; BLADDER NECK STENOSIS; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CLINICAL RESEARCH; DIAGNOSTIC ACCURACY; DIURNAL ENURESIS; DRUG EFFICACY; DYSURIA; HUMAN; IMPAIRED BLADDER EMPTYING; INTERMITTENT CATHETERIZATION; LOWER URINARY TRACT SYMPTOM; MEASUREMENT; MICTURITION DISORDER; NEUROMODULATION; NOCTURIA; NOCTURNAL ENURESIS; OVERACTIVE BLADDER; PATHOPHYSIOLOGY; POSTVOID RESIDUAL URINE VOLUME; PRACTICE GUIDELINE; PREVALENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STRESS INCONTINENCE; SYSTEMATIC REVIEW; URETHRAL CATHETERIZATION; URINARY DYSFUNCTION; URINARY FREQUENCY; URINARY HESITANCY; URINARY URGENCY; WOMEN'S HEALTH;

FEMALE; HUMANS; URINARY BLADDER NECK OBSTRUCTION; URINARY BLADDER, OVERACTIVE; URINATION DISORDERS; URODYNAMICS;

EID: 84860218900     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.21252     Document Type: Review

References (43)

1. Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study. Eur Urol 2006; 50: 1306-15. (Pubitemid 44692945)
2. Fowler CJ, Griffiths D, De Groat WC,. The neural control of micturition. Nat Rev Neurosci 2008; 9: 453-66. (Pubitemid 351704950)
3. Sullivan MP, Yalla SV,. Physiology of female micturition. Urol Clin North Am 2002; 29: 499-514. (Pubitemid 35417164)
4. Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 2010; 21: 5-26.
5. Groutz A, Blaivas JG, Sassone AM,. Detrusor pressure uroflowmetry studies in women: Effect of a 7Fr transurethral catheter. J Urol 2000; 164: 109-14. (Pubitemid 30434271)
6. Massolt ET, Groen J, Vierhout ME,. Application of the Blaivas-Groutz bladder outlet obstruction nomogram in women with urinary incontinence. Neurourol Urodyn 2005; 24: 237-42. (Pubitemid 40617097)
7. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function. Report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167-78. (Pubitemid 34195211)
8. Abrams P, Andersson KE, Birder L, et al. Fourth International Consultation on Incontinence. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn 2010; 29: 213-40.
9. Nabi G, Cody JD, Ellis G, et al. Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. Cochrane Database Syst Rev 2006; 18: CD003781.
10. Kupelian V, Wei J, O'Leary M, et al. Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: The Boston Area Community Health (BACH) survey. Arch Intern Med 2006; 166: 2381-7. (Pubitemid 44833365)
11. Maserejian NN, Kupelian V, McVary KT, et al. Prevalence of post-micturition symptoms in association with lower urinary tract symptoms,health-related quality of life in men,women. BJU Int 2011; DOI: 10.1111/j.1464-410X.2010.10014.x. [Epub ahead of print].
12. Coyne K, Sexton C, Kopp Z, et al. The prevalence,bother,overlap of LUTS in the US, UK, Sweden: EpiLUTS. Eur Urol Suppl 2008; 7: 238.
13. Kirby M, Artibani W, Cardozo L, et al. Overactive bladder: The importance of new guidance. Int J Clin Pract 2006; 60: 1263-71. (Pubitemid 44363664)
14. Thüroff JW, Abrams P, Andersson KE, et al. EAU Guidelines on Urinary Incontinence. Eur Urol 2011; 59: 387-400.
15. Al-Shahrani M, Lovatsis D,. Do subjective symptoms of obstructive voiding correlate with post-void residual urine volume in women ? Int Urogynecol J Pelvic Floor Dysfunct 2005; 16: 12-14. (Pubitemid 40109748)
16. Lowenstein L, Anderson C, Kenton K, et al. Obstructive voiding symptoms are not predictive of elevated postvoid residual urine volumes. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19: 801-4. (Pubitemid 351597557)
17. Gehrich A, Stany MP, Fischer JR, et al. Establishing a mean postvoid residual volume in asymptomatic perimenopausal and postmenopausal women. Obstet Gynecol 2007; 110: 827-32. (Pubitemid 47508747)
18. Fitzgerald MP, Jaffar J, Brubaker L,. Risk factors for an elevated postvoid residual urine volume in women with symptoms of urinary urgency, frequency and urge incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2001; 12: 237-9.
19. Milleman M, Langenstroer P, Guralnick ML,. Post-void residual urine volume in women with overactive bladder symptoms. J Urol 2004; 172: 1911-14. (Pubitemid 39363088)
20. Lukacz ES, DuHamel E, Menefee SA, et al. Elevated postvoid residual in women with pelvic floor disorders: Prevalence and associated risk factors. Int Urogynecol J 2007; 18: 397-400. (Pubitemid 46390132)
21. Haylen BT, Lee J, Logan V, et al. Immediate postvoid residual volumes in women with symptoms of pelvic floor dysfunction. Obstet Gynecol 2008; 111: 1305-12.
22. Nitti VW, Tu LM, Gitlin J,. Diagnosing bladder outlet obstruction in women. J Urol 1999; 161: 1535-40. (Pubitemid 29420814)
23. Groutz A, Blaivas J, Chaikin D,. Bladder outlet obstruction in women: Definition and characteristics. Neurourol Urodyn 2000; 19: 213-20. (Pubitemid 30253978)
24. Kuo HC,. Videourodynamic characteristics and lower urinary tract symptoms of female bladder outlet obstruction. Urology 2005; 66: 1005-9.
25. Duckett J, Basu M,. The predictive value of pre-operative pressure flow studies in the resolution of detrusor overactivity and overactive bladder after tension-free vaginal tape insertion. BJU Int 2007; 99: 1439-42. (Pubitemid 47164813)
26. Kayigil O, Metin A, Atmaca A,. Obstructive urodynamic findings in idiopathic detrusor overactivity. Int Urol Nephrol 2007; 39: 445-8. (Pubitemid 47054842)
27. Wu WY, Hsiao SM, Chang TC, et al. Changes in urodynamic parameters after tolterodine treatment for female overactive bladder syndrome with or without voiding dysfunction. J Obstet Gynaecol Res 2011; 37: 436-41.
28. Basu M, Duckett JRA,. Effect of urethral dilatation on women with voiding dysfunction. Curr Bladder Dysfunct Rep 2010; 5: 23-6.
29. Fletcher SG, Haverkorn RM, Yan J, et al. Demographic and urodynamic factors associated with persistent OAB after anterior compartment prolapse repair. Neurourol Urodyn 2010; 29: 1414-18.
30. Digesu GA, Salvatore S, Chaliha C, et al. Do overactive bladder symptoms improve after repair of anterior vaginal wall prolapse ? Int Urogynecol J Pelvic Floor Dysfunct 2007; 18: 1439-43. (Pubitemid 350066279)
31. Foster RT Sr, Barber MD, Parasio MF, et al. A prospective assessment of overactive bladder symptoms in a cohort of elderly women who underwent transvaginal surgery for advanced pelvic organ prolapse. Am J Obstet Gynecol 2007; 197: 82.e1-84.
32. Daneshgari F, Kong W, Swartz M,. Complications of mid urethral slings: Important outcomes for future clinical trials. J Urol 2008; 180: 1890-7.
33. Chapple CR, Wein AJ, Abrams P, et al. Lower urinary tract symptoms revisited: A broader clinical perspective. Eur Urol 2008; 54: 563-9.
34. Starkman JS, Duffy JW III, Wolter CE, et al. The evolution of obstruction induced overactive bladder symptoms following urethrolysis for female bladder outlet obstruction. J Urol 2008; 179: 1018-23.
35. Basu M, Duckett J,. The effect of urethral dilatation on pressure flow studies in women with voiding dysfunction and overactive bladder. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20: 1073-7.
36. Santucci RA, Payne CK, Saigai CS, et al. Office dilation of the female urethra: A quality of care problem in the field of urology. J Urol 2008; 180: 2068-75.
37. Keegan KA, Nanigian DK, Stone AR,. Female urethral stricture disease. Curr Urol Rep 2008; 9: 419-23.
38. Costantini E, Lazzeri M, Bini V, et al. Open-label, longitudinal study of tamsulosin for functional bladder outlet obstruction in women. Urol Int 2009; 83: 311-5.
39. Robinson D, Cardozo L, Terpstra G, et al. A randomized double-blind placebo-controlled multicentre study to explore the efficacy and safety of tamsulosin and tolterodine in women with overactive bladder syndrome. BJU Int 2007; 100: 840-5. (Pubitemid 47360202)
40. Koh JS, Kim SJ, Kim HS, et al. Comparison of alpha-blocker, extracorporeal magnetic stimulation alone and in combination in the management of female bladder outlet obstruction. Int Urogynecol J Pelvic Floor Dysfunct 2011; 22: 849-54.
41. Dasgupta R, Fowler CJ,. The management of female voiding dysfunction: Fowler's syndrome-A contemporary update, Curr Opin Urol 2003; 13: 293-9. (Pubitemid 36900668)
42. Van Kerrebroeck P, van Voskuilen A, Lycklama a Nijeholt AA, et al. Long-term results of Interstim therapy for voiding disorders demonstrate sustained efficacy and acceptable safety profile. Eur Urol Suppl 2004; 2: 170.
43. Dasgupta R, Critchley HD, Dolan RJ, et al. Changes in brain activity following sacral neuromodulation for urinary retention. J Urol 2005; 174: 2268-72. (Pubitemid 41611799)